Sign inGet started

NXTC

NextCure, Inc.CIK 1661059 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
$53.7K
3 trades · 1 insiders
Open-mkt sales · 90d
$369.6K
2 trades · 2 insiders
Net · 90d
$-315.9K
Insiders on file
31

AI insights for NXTC PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for NXTC
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$369.6K2026-08-10 buys — 2026-08-10 sales $369.6K08-102026-10-23 buys $27.2K 2026-10-23 sales —10-232026-10-26 buys $8.4K 2026-10-26 sales —10-262026-10-27 buys $18.1K 2026-10-27 sales —10-27
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
ADAR1 Capital Management, LLC10% Owner29$3.48M$02026-10-27
Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd.Other1$0$184.8K2026-08-10
Simcere Zaiming, Inc.Other1$0$184.8K2026-08-10
Borgman Anne ElizabethDirector7$0$02026-06-18
Feigal EllenDirector7$0$02026-06-18
Houston John GDirector8$0$02026-06-18
Webster Stephen WDirector8$0$02026-06-18
Jones Elaine VDirector8$0$02026-06-18
KABAKOFF DAVID SDirector8$0$02026-06-18
Guha UdayanChief Medical Officer1$0$02026-01-30
Shaw Kevin G.Sr VP, Legal Affairs5$0$02026-01-30
Kundu SouravSr VP, Dev. & Mfg.7$0$02026-01-30
Mayer TimothyChief Operating Officer8$0$02026-01-30
Cobourn Steven P.Chief Financial Officer8$0$02026-01-30
Richman MichaelPresident & CEO8$0$02026-01-30
Langermann SolChief Scientific Officer7$0$02025-01-31
Myint HanChief Medical Officer5$0$02024-03-29
Nicholson Garry ADirector5$0$02023-06-22
Khuong Chau QuangDirector14$5.25M$02023-06-22
Liu LindaSVP, Research7$0$02022-01-31
Xu StellaDirector6$1.88M$02021-06-24
Heller Kevin N.Chief Medical Officer3$0$02020-07-14
Li JudithDirector2$0$02020-06-11
Morrison BriggsDirector2$0$02020-06-11
Bingham James B.Chief Development Officer1$0$02020-02-28
Sofinnova Venture Partners IX, L.P.10% Owner1$5.51M$02019-11-15
SHANNON TIMOTHY MDirector10$750.0K$02019-06-13
Alexandria Venture Investments, LLC10% Owner5$0$02019-05-13
OrbiMed Capital GP VI LLCDirector, 10% Owner9$5.25M$02019-05-13
CANAAN X L.P.10% Owner9$750.0K$02019-05-13
Sofinnova Management IX, L.L.C.10% Owner9$6.00M$02019-05-13

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
ADAR1 Capital Management, LLC10% Owner P Buy2026-10-272026-10-273,553$5.10 $18.1K733,270SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-10-262026-10-271,672$5.03 $8.4K729,717SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-10-232026-10-275,626$4.83 $27.2K728,045SEC↗
Jiangsu Simcere Zaiming PharmaOther S Sale2026-08-102026-08-1230,000$6.16 $184.8K308,636SEC↗
Simcere Zaiming, Inc.Other S Sale2026-08-102026-08-1230,000$6.16 $184.8K308,636SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-312026-08-0325,000$4.98 $124.5K714,416SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-312026-08-033,300$4.98 $16.4K689,416SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-312026-08-038,003$4.80 $38.4K722,419SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-312026-08-038,003$4.80 $38.4K722,419SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-312026-08-0325,000$4.98 $124.5K714,416SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-312026-08-033,300$4.98 $16.4K689,416SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-03100,000$4.90 $490.0K608,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0377,850$4.96 $386.1K686,116SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0325,000$4.81 $120.2K508,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0320,000$5.00 $100.0K483,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0320,000$5.00 $100.0K463,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0350,000$4.97 $248.5K443,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0377,850$4.96 $385.8K686,116SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-03100,000$4.90 $490.0K608,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0325,000$4.81 $120.3K508,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0320,000$5.00 $100.0K483,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0320,000$5.00 $100.0K463,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-302026-08-0350,000$4.97 $248.6K443,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-292026-07-291,600$5.00 $8.0K393,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-292026-07-291,810$5.00 $9.1K391,666SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-292026-07-291,600$5.00 $8.0K393,266SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-292026-07-291,810$5.00 $9.1K391,666SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-282026-07-296,400$4.95 $31.7K389,856SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-282026-07-296,400$4.95 $31.7K389,856SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-272026-07-297,798$5.00 $39.0K383,456SEC↗
ADAR1 Capital Management, LLC10% Owner P Buy2026-07-272026-07-297,798$5.00 $39.0K383,456SEC↗
KABAKOFF DAVID SDirector A Award deriv2026-06-182026-06-223,510— $03,510SEC↗
Jones Elaine VDirector A Award deriv2026-06-182026-06-222,340— $02,340SEC↗
Borgman Anne ElizabethDirector A Award deriv2026-06-182026-06-222,340— $02,340SEC↗
Webster Stephen WDirector A Award deriv2026-06-182026-06-222,340— $02,340SEC↗
Houston John GDirector A Award deriv2026-06-182026-06-222,340— $02,340SEC↗
Feigal EllenDirector A Award deriv2026-06-182026-06-222,340— $02,340SEC↗
Mayer TimothyChief Operating Officer A Award deriv2026-01-302026-02-0314,670— $014,670SEC↗
Richman MichaelPresident & CEO A Award deriv2026-01-302026-02-0338,190— $038,190SEC↗
Shaw Kevin G.Sr VP, General Counsel A Award deriv2026-01-302026-02-038,270— $08,270SEC↗
Kundu SouravSr VP, Dev. & Mfg. A Award deriv2026-01-302026-02-038,270— $08,270SEC↗
Cobourn Steven P.Chief Financial Officer A Award deriv2026-01-302026-02-0314,670— $014,670SEC↗
Guha UdayanChief Medical Officer A Award deriv2026-01-302026-02-0314,670— $014,670SEC↗
Feigal EllenDirector A Award deriv2025-06-202025-06-2418,700— $018,700SEC↗
Webster Stephen WDirector A Award deriv2025-06-202025-06-2418,700— $018,700SEC↗
Borgman Anne ElizabethDirector A Award deriv2025-06-202025-06-2418,700— $018,700SEC↗
KABAKOFF DAVID SDirector A Award deriv2025-06-202025-06-2428,050— $028,050SEC↗
Jones Elaine VDirector A Award deriv2025-06-202025-06-2418,700— $018,700SEC↗
Houston John GDirector A Award deriv2025-06-202025-06-2418,700— $018,700SEC↗
Richman MichaelPresident & CEO A Award deriv2025-01-312025-02-03305,500— $0305,500SEC↗
Cobourn Steven P.Chief Financial Officer A Award deriv2025-01-312025-02-03117,375— $0117,375SEC↗
Kundu SouravSr VP, Dev. & Mfg. A Award deriv2025-01-312025-02-0366,125— $066,125SEC↗
Langermann SolChief Scientific Officer A Award deriv2025-01-312025-02-03117,375— $0117,375SEC↗
Mayer TimothyChief Operating Officer A Award deriv2025-01-312025-02-03117,375— $0117,375SEC↗
Shaw Kevin G.Sr VP, General Counsel A Award deriv2025-01-312025-02-0366,125— $066,125SEC↗
Borgman Anne ElizabethDirector A Award deriv2024-06-202024-06-2118,700— $018,700SEC↗
Feigal EllenDirector A Award deriv2024-06-202024-06-2118,700— $018,700SEC↗
Houston John GDirector A Award deriv2024-06-202024-06-2118,700— $018,700SEC↗
Jones Elaine VDirector A Award deriv2024-06-202024-06-2118,700— $018,700SEC↗
KABAKOFF DAVID SDirector A Award deriv2024-06-202024-06-2128,050— $028,050SEC↗
Webster Stephen WDirector A Award deriv2024-06-202024-06-2118,700— $018,700SEC↗
Cobourn Steven P.Chief Financial Officer A Award deriv2024-03-292024-04-0293,900— $093,900SEC↗
Kundu SouravSr VP, Dev. & Mfg. A Award deriv2024-03-292024-04-0252,900— $052,900SEC↗
Langermann SolChief Scientific Officer A Award deriv2024-03-292024-04-0293,900— $093,900SEC↗
Mayer TimothyChief Operating Officer A Award deriv2024-03-292024-04-0293,900— $093,900SEC↗
Myint HanChief Medical Officer A Award deriv2024-03-292024-04-0293,900— $093,900SEC↗
Richman MichaelPresident & CEO A Award deriv2024-03-292024-04-02244,400— $0244,400SEC↗
Shaw Kevin G.Sr VP, General Counsel A Award deriv2024-03-292024-04-0293,900— $093,900SEC↗
Cobourn Steven P.Chief Financial Officer A Award deriv2024-01-312024-02-01117,375— $0117,375SEC↗
Kundu SouravSr VP, Dev. & Mfg. A Award deriv2024-01-312024-02-0166,125— $066,125SEC↗
Langermann SolChief Scientific Officer A Award deriv2024-01-312024-02-01117,375— $0117,375SEC↗
Mayer TimothyChief Operating Officer A Award deriv2024-01-312024-02-01117,375— $0117,375SEC↗
Myint HanChief Medical Officer A Award deriv2024-01-312024-02-01117,375— $0117,375SEC↗
Richman MichaelPresident & CEO A Award deriv2024-01-312024-02-01305,500— $0305,500SEC↗
Shaw Kevin G.Sr VP, General Counsel A Award deriv2024-01-312024-02-0166,125— $066,125SEC↗
Borgman Anne ElizabethDirector A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
Webster Stephen WDirector A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
Jones Elaine VDirector A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
Feigal EllenDirector A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
Houston John GDirector A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
Khuong Chau QuangDirector A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
KABAKOFF DAVID SDirector A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
Nicholson Garry ADirector A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
Cobourn Steven P.Chief Financial Officer A Award deriv2023-02-282023-03-01135,000— $0135,000SEC↗
Richman MichaelPresident & CEO A Award deriv2023-02-282023-03-01309,000— $0309,000SEC↗
Langermann SolChief Scientific Officer A Award deriv2023-02-282023-03-01135,000— $0135,000SEC↗
Shaw Kevin G.Sr VP, Legal Affairs A Award deriv2023-02-282023-03-0175,000— $075,000SEC↗
Myint HanChief Medical Officer A Award deriv2023-02-282023-03-01135,000— $0135,000SEC↗
Kundu SouravSr VP, Dev. & Mfg. A Award deriv2023-02-282023-03-0175,000— $075,000SEC↗
Mayer TimothyChief Operating Officer A Award deriv2023-02-282023-03-01135,000— $0135,000SEC↗
KABAKOFF DAVID SDirector A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
Jones Elaine VDirector A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
Khuong Chau QuangDirector A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
Webster Stephen WDirector A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
Nicholson Garry ADirector A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
Houston John GDirector A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
Borgman Anne ElizabethDirector A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
Feigal EllenDirector A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
Myint HanChief Medical Officer A Award deriv2022-01-312022-02-02103,600— $0103,600SEC↗
Cobourn Steven P.Chief Financial Officer A Award deriv2022-01-312022-02-0296,700— $096,700SEC↗
Mayer TimothyChief Operating Officer A Award deriv2022-01-312022-02-02131,200— $0131,200SEC↗
Richman MichaelPresident & CEO A Award deriv2022-01-312022-02-02262,400— $0262,400SEC↗
Kundu SouravSr VP, Dev. & Mfg. A Award deriv2022-01-312022-02-0258,700— $058,700SEC↗
Langermann SolChief Scientific Officer A Award deriv2022-01-312022-02-02117,400— $0117,400SEC↗
Liu LindaSVP, Research A Award deriv2022-01-312022-02-0265,600— $065,600SEC↗
Borgman Anne ElizabethDirector A Award deriv2021-10-012021-10-0528,500— $028,500SEC↗
Borgman Anne ElizabethDirector A Award deriv2021-10-012021-10-0510,384— $010,384SEC↗
Feigal EllenDirector A Award deriv2021-10-012021-10-0510,384— $010,384SEC↗
Feigal EllenDirector A Award deriv2021-10-012021-10-0528,500— $028,500SEC↗
Kundu SouravSr VP, Dev. & Mfg. A Award deriv2021-07-152021-07-19150,000— $0150,000SEC↗
Khuong Chau QuangDirector A Award deriv2021-06-242021-06-2814,250— $014,250SEC↗
Webster Stephen WDirector A Award deriv2021-06-242021-06-2814,250— $014,250SEC↗
Jones Elaine VDirector A Award deriv2021-06-242021-06-2814,250— $014,250SEC↗
KABAKOFF DAVID SDirector A Award deriv2021-06-242021-06-2814,250— $014,250SEC↗
Xu StellaDirector A Award deriv2021-06-242021-06-2814,250— $014,250SEC↗
Nicholson Garry ADirector A Award deriv2021-06-242021-06-2814,250— $014,250SEC↗
Houston John GDirector A Award deriv2021-06-242021-06-2814,250— $014,250SEC↗
Cobourn Steven P.Chief Financial Officer A Award deriv2021-03-152021-03-16100,000— $0100,000SEC↗
Langermann SolChief Scientific Officer A Award deriv2021-03-152021-03-16100,000— $0100,000SEC↗
Liu LindaSVP, Research A Award deriv2021-03-152021-03-16100,000— $0100,000SEC↗
Mayer TimothyChief Operating Officer A Award deriv2021-03-152021-03-16100,000— $0100,000SEC↗
Richman MichaelPresident & CEO A Award deriv2021-03-152021-03-16300,000— $0300,000SEC↗
Myint HanChief Medical Officer A Award deriv2021-01-132021-01-19200,000— $0200,000SEC↗
Houston John GDirector A Award deriv2020-09-102020-09-1428,500— $028,500SEC↗
Houston John GDirector A Award deriv2020-09-102020-09-1410,687— $010,687SEC↗
Heller Kevin N.Chief Medical Officer M Exercise deriv2020-07-142020-07-1627,229— $038,119SEC↗
Heller Kevin N.Chief Medical Officer M Exercise2020-07-142020-07-1627,229$1.77 $48.2K49,011SEC↗
Nicholson Garry ADirector A Award deriv2020-06-112020-06-1528,500— $028,500SEC↗
Nicholson Garry ADirector A Award deriv2020-06-112020-06-1516,083— $016,083SEC↗
KABAKOFF DAVID SDirector A Award deriv2020-06-112020-06-1514,250— $014,250SEC↗
Jones Elaine VDirector A Award deriv2020-06-112020-06-1514,250— $014,250SEC↗
Khuong Chau QuangDirector A Award deriv2020-06-112020-06-1514,250— $014,250SEC↗
Li JudithDirector A Award deriv2020-06-112020-06-1514,250— $014,250SEC↗
Morrison BriggsDirector A Award deriv2020-06-112020-06-1514,250— $014,250SEC↗
Webster Stephen WDirector A Award deriv2020-06-112020-06-1514,250— $014,250SEC↗
Xu StellaDirector A Award deriv2020-06-112020-06-1514,250— $014,250SEC↗
Richman MichaelPresident & CEO A Award deriv2020-02-282020-03-03225,000— $0225,000SEC↗
Mayer TimothyChief Operating Officer A Award deriv2020-02-282020-03-0378,200— $078,200SEC↗
Liu LindaSVP, Research A Award deriv2020-02-282020-03-0339,100— $039,100SEC↗
Langermann SolChief Scientific Officer A Award deriv2020-02-282020-03-0378,200— $078,200SEC↗
Heller Kevin N.Chief Medical Officer A Award deriv2020-02-282020-03-03100,050— $0100,050SEC↗
Cobourn Steven P.Chief Financial Officer A Award deriv2020-02-282020-03-0378,200— $078,200SEC↗
Bingham James B.Chief Development Officer A Award deriv2020-02-282020-03-0378,200— $078,200SEC↗
Liu LindaSVP, Research M Exercise deriv2019-11-272020-02-2120,745— $010,373SEC↗
Liu LindaSVP, Research M Exercise deriv2019-11-272020-02-2134,489— $09,076SEC↗
Liu LindaSVP, Research M Exercise2019-11-272020-02-2120,745$1.21 $25.1K55,234SEC↗
Liu LindaSVP, Research M Exercise2019-11-272020-02-2134,489$0.48 $16.6K34,489SEC↗
Sofinnova Venture Partners IX,10% Owner P Buy2019-11-152019-11-19150,000$36.75 $5.51M2,671,856SEC↗
Xu StellaDirector A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
Webster Stephen WDirector A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
SHANNON TIMOTHY MDirector A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
Morrison BriggsDirector A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
Li JudithDirector A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
Khuong Chau QuangDirector A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
KABAKOFF DAVID SDirector A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
Jones Elaine VDirector A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner C Conversion deriv2019-05-132019-05-135,970,000— $00SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner C Conversion deriv2019-05-132019-05-133,554,466— $00SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner C Conversion deriv2019-05-132019-05-135,861,455— $00SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner C Conversion deriv2019-05-132019-05-133,582,000— $00SEC↗
CANAAN X L.P.10% Owner C Conversion deriv2019-05-132019-05-133,582,000— $00SEC↗
CANAAN X L.P.10% Owner C Conversion deriv2019-05-132019-05-132,296,605— $00SEC↗
CANAAN X L.P.10% Owner C Conversion deriv2019-05-132019-05-135,861,455— $00SEC↗
CANAAN X L.P.10% Owner C Conversion deriv2019-05-132019-05-135,970,000— $00SEC↗
Xu StellaDirector C Conversion deriv2019-05-132019-05-137,861,636— $00SEC↗
Khuong Chau QuangDirector C Conversion deriv2019-05-132019-05-133,582,000— $00SEC↗
Khuong Chau QuangDirector C Conversion deriv2019-05-132019-05-135,861,455— $00SEC↗
Khuong Chau QuangDirector C Conversion deriv2019-05-132019-05-135,970,000— $00SEC↗
Khuong Chau QuangDirector C Conversion deriv2019-05-132019-05-133,554,466— $00SEC↗
SHANNON TIMOTHY MDirector C Conversion deriv2019-05-132019-05-132,296,605— $00SEC↗
SHANNON TIMOTHY MDirector C Conversion deriv2019-05-132019-05-135,861,455— $00SEC↗
SHANNON TIMOTHY MDirector C Conversion deriv2019-05-132019-05-135,970,000— $00SEC↗
SHANNON TIMOTHY MDirector C Conversion deriv2019-05-132019-05-133,582,000— $00SEC↗
Alexandria Venture Investments10% Owner C Conversion deriv2019-05-132019-05-13223,500— $00SEC↗
Alexandria Venture Investments10% Owner C Conversion deriv2019-05-132019-05-13372,500— $00SEC↗
Alexandria Venture Investments10% Owner C Conversion deriv2019-05-132019-05-13628,931— $00SEC↗
Alexandria Venture Investments10% Owner C Conversion deriv2019-05-132019-05-13365,727— $00SEC↗
Sofinnova Management IX, L.L.C10% Owner C Conversion deriv2019-05-132019-05-153,773,585— $00SEC↗
Sofinnova Management IX, L.L.C10% Owner C Conversion deriv2019-05-132019-05-157,301,000— $00SEC↗
Sofinnova Management IX, L.L.C10% Owner C Conversion deriv2019-05-132019-05-153,732,500— $00SEC↗
Sofinnova Management IX, L.L.C10% Owner C Conversion deriv2019-05-132019-05-152,239,500— $00SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner P Buy2019-05-132019-05-13350,000$15.00 $5.25M2,711,013SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner C Conversion2019-05-132019-05-13442,438— $02,361,013SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner C Conversion2019-05-132019-05-13445,866— $0445,866SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner C Conversion2019-05-132019-05-13743,110— $01,188,976SEC↗
OrbiMed Capital GP VI LLCDirector, 10% Owner C Conversion2019-05-132019-05-13729,599— $01,918,575SEC↗
CANAAN X L.P.10% Owner C Conversion2019-05-132019-05-13743,110— $01,188,976SEC↗
CANAAN X L.P.10% Owner C Conversion2019-05-132019-05-13285,867— $02,204,442SEC↗
CANAAN X L.P.10% Owner C Conversion2019-05-132019-05-13729,599— $01,918,575SEC↗
CANAAN X L.P.10% Owner C Conversion2019-05-132019-05-13445,866— $0445,866SEC↗
CANAAN X L.P.10% Owner P Buy2019-05-132019-05-1350,000$15.00 $750.0K2,254,442SEC↗
Xu StellaDirector P Buy2019-05-132019-05-13125,000$15.00 $1.88M1,103,570SEC↗
Xu StellaDirector C Conversion2019-05-132019-05-13978,570— $0978,570SEC↗
Khuong Chau QuangDirector C Conversion2019-05-132019-05-13442,438— $02,361,013SEC↗
Khuong Chau QuangDirector P Buy2019-05-132019-05-13350,000$15.00 $5.25M2,711,013SEC↗
Khuong Chau QuangDirector C Conversion2019-05-132019-05-13445,866— $0445,866SEC↗
Khuong Chau QuangDirector C Conversion2019-05-132019-05-13743,110— $01,188,976SEC↗
Khuong Chau QuangDirector C Conversion2019-05-132019-05-13729,599— $01,918,575SEC↗
SHANNON TIMOTHY MDirector P Buy2019-05-132019-05-1350,000$15.00 $750.0K2,254,442SEC↗
SHANNON TIMOTHY MDirector C Conversion2019-05-132019-05-13445,866— $0445,866SEC↗
SHANNON TIMOTHY MDirector C Conversion2019-05-132019-05-13743,110— $01,188,976SEC↗
SHANNON TIMOTHY MDirector C Conversion2019-05-132019-05-13729,599— $01,918,575SEC↗
SHANNON TIMOTHY MDirector C Conversion2019-05-132019-05-13285,867— $02,204,442SEC↗
Alexandria Venture Investments10% Owner C Conversion2019-05-132019-05-13197,993— $0197,993SEC↗
Sofinnova Management IX, L.L.C10% Owner C Conversion2019-05-132019-05-15464,599— $0743,358SEC↗
Sofinnova Management IX, L.L.C10% Owner C Conversion2019-05-132019-05-15908,785— $01,652,143SEC↗
Sofinnova Management IX, L.L.C10% Owner C Conversion2019-05-132019-05-15469,713— $02,121,856SEC↗
Sofinnova Management IX, L.L.C10% Owner C Conversion2019-05-132019-05-15278,759— $0278,759SEC↗
Sofinnova Management IX, L.L.C10% Owner P Buy2019-05-132019-05-15400,000$15.00 $6.00M2,521,856SEC↗